Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
12/2010
12/30/2010US20100330122 VARICELLA ZOSTER VIRUS VIRUS-LIKE PARTICLES (VLPs) AND ANTIGENS
12/30/2010US20100330121 Recombinant alphavirus-based vectors with reduced inhibition of cellular macro-molecular synthesis
12/30/2010US20100330120 Human parainfluenza viruses having separated p and c genes
12/30/2010US20100330119 Chromatography medium, preparation method of the same, and method for producing virus vaccine using the chromatography medium
12/30/2010US20100330118 Influenza hemagglutinin and neuraminidase variants
12/30/2010US20100330117 Process for treatment of amyotrophic lateral sclerosis, rheumatoid arthritis, tremors/parkinson's disease, multiple sclerosis, non-viral based cancers, alzheimers's disease, muscular dystrophy, attention deficit disorder, attention deficit hyperactivity disorder, complex regional pain syndrome, diabetes, neuropathic pain, spider arthritis, west nile virus, fibromyalgia, shingles, gout, migraine headaches, senile dementia, post polio syndrome, central virus deafness, asthma, chronic pain of unknown origin and hepatitis c
12/30/2010US20100330116 Live attenuated salmonella for use as vaccine
12/30/2010US20100330115 Multivariable Antigens Complexed with Targeting Humanized Monoclonal Antibody
12/30/2010US20100330114 Use of SIRT1 Activators or Inhibitors to Modulate an Immune Response
12/30/2010US20100330111 Increase of immune response and targeting by antigens and/or drug linkage
12/30/2010US20100330110 Therapeutic and diagnostic uses of antibody specificity profiles
12/30/2010US20100330109 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
12/30/2010US20100330105 Anticancer Combination Therapies
12/30/2010US20100330101 BIFUNCTIONAL CpG OR OLIGO-/POLYNUCLEOTIDE AND TOXIN OR ENTEROTOXIN CONTAINING COMPOSITION
12/30/2010US20100330094 Anti-IP-10 Antibodies and Methods of Use Thereof
12/30/2010US20100330089 Anti-cd20 therapeutic compositions and methods
12/30/2010US20100330088 Strategies to prevent and/or treat immunie responses to soluble allofactors
12/30/2010US20100330077 1-acetic acid-indole derivatives with pgd2 antagonist activity
12/30/2010US20100330076 Immunoglobulin fc polypeptides
12/30/2010US20100330071 Method to produce a highly concentrated immunoglobulin preparation for subcutaneous use
12/30/2010US20100330070 Methods Of Making An Antibody And Compositions Thereof
12/30/2010US20100330057 Method of evaluating human dentritic cells and human cell immunotherapeutic agent
12/30/2010US20100330056 Enhanced generation of cytotoxic t-lymphocytes by il-21 mediated foxp3 suppression
12/30/2010US20100330034 Use of bispecific antibodies to regulate immune responses
12/30/2010US20100330029 Cancer Treatments with Radiation and Immunocytokines
12/30/2010US20100329998 Novel heterocycles
12/30/2010US20100329985 Treatment and prevention of inflammatory diseases and autoimmune diseases
12/30/2010US20100329984 Respiratory dispersion for metered dose inhalers
12/30/2010US20100329980 Humanized anti-alpha 9 integrin antibodies and the uses thereof
12/29/2010WO2010150867A1 Fermentation product of a cereal-derived material and immunomodulator
12/29/2010WO2010150865A1 Crystals
12/29/2010WO2010150255A1 Conjugates of cytotoxic drugs
12/29/2010WO2010149771A1 Novel compound useful for the treatment of degenerative and inflammatory diseases
12/29/2010WO2010148650A1 5-membered heteroaryl derivatives used as sphingosine 1-phosphate receptor agonists
12/29/2010WO2010148649A1 5-membered heteroaryl derivatives used as sphingosine 1-phosphate receptor agonists
12/29/2010WO2010148577A1 Antitumor and immunity-regulating pharmaceutical composition of traditional chinese medicine, preparation method and use for same
12/29/2010WO2010148459A1 Synthetic operon
12/29/2010WO2010148434A1 Chimeric molecules
12/29/2010WO2010083253A3 Cd47 related compositions and methods for treating immunological diseases and disorders
12/29/2010WO2010078730A9 Preparation of ginsenoside-rd propylene glycol aqueous solution and new use thereof in anti-inflammation, immunosuppression and anti organ-graft rejection
12/29/2010WO2010072327A3 Pharmaceutical composition based on peptide from camel milk
12/29/2010EP2267452A1 A soluble complex comprising a retroviral surface glycoprotein
12/29/2010EP2267118A1 Method for production of transfected cell
12/29/2010EP2267032A2 Method of administering therapeutic polypeptides, and polypeptides therefor
12/29/2010EP2267029A2 Methods and compositions for treatment of inflammatory disease using Cadherin-11 modulating agents
12/29/2010EP2267027A2 Method of administering therapeutic polypeptides, and polypeptides therefor
12/29/2010EP2267026A1 Albumin fusion proteins
12/29/2010EP2266665A1 Method for the improvement of islet signaling in diabetes mellitus and for its prevention
12/29/2010EP2266626A1 Composition for external application comprising transcription factor decoy as active ingredient
12/29/2010EP2266624A2 Duramycin peptide binding to anionic phospholipids and aminophospholipids conjugates and their use in treating viral infections
12/29/2010EP2266607A2 Immunoconjugates for treating cancer
12/29/2010EP2266604A2 Adjuvant systems and vaccines
12/29/2010EP2266603A1 Tumour vaccines
12/29/2010EP2266580A1 Medicament comprising a reducing alkyl-sugar monomer for the treatment of inflammatory disorders
12/29/2010EP2266557A1 Method of utilization of combination of benzophenone derivative or salt thereof and immunosuppressing agent, and pharmaceutical composition comprising these components
12/29/2010EP2266530A1 Oxazolidinones for cosmetic cutaneous use
12/29/2010EP2265644A1 A monoclonal antibody and a method thereof
12/29/2010EP2265643A1 Agent for treating disease
12/29/2010EP2265635A1 Modified cpn10 and prr signalling
12/29/2010EP2265584A1 Hydroxyalkanyl amides as modulators of chemokine receptor activity
12/29/2010EP2265279A1 Use of the pat nonapeptide in the treatment of autoimmune diseases
12/29/2010EP1856153B1 Ykl-40 monoclonal antibodies
12/29/2010EP1791830B1 Diaminotriazole compounds useful as protein kinase inhibitors
12/29/2010EP1758578B1 Novel indazole carboxamides and their use
12/29/2010EP1530568B1 INDOLE OR BENZIMIDAZOLE DERIVATIVES FOR MODULATING I&kB KINASE
12/29/2010EP1438052B1 Quinazolin-4-ones as inhibitors of human phosphatidylinositol 3-kinase delta
12/29/2010EP1425305B1 Igf-1 as feline vaccine adjuvant, in particular against feline retroviruses
12/29/2010EP1286657B1 Nasal ointment based on white petroleum jelly
12/29/2010CN1969984B Externally applied medicament for treating acne and allergy
12/29/2010CN1922139B Bicyclic amide derivatives
12/29/2010CN1899361B Zhenqi medicinal composition and its preparation
12/29/2010CN101932599A Molecule and chimeric molecules thereof
12/29/2010CN101932597A Novel wheat allergens
12/29/2010CN101932575A Piperidine derivative
12/29/2010CN101928745A Preparation method and applications of ant polypeptide
12/29/2010CN101928709A Gene sequence, recombinant expression and application of hyalomma asiaticum histamine binding protein (HaHBP)
12/29/2010CN101928344A Human monoclonal antibodies against cd20
12/29/2010CN101928284A Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient
12/29/2010CN101928262A Biologically active methylene blue derivatives
12/29/2010CN101928234A 6/7-(hetero)aryl-N-hydroxyl hexanamide/heptamide compounds and method for preparing same
12/29/2010CN101926993A Adjuvant systems and vaccines
12/29/2010CN101926950A Brain-invigorating traditional Chinese medicine composite and preparation method and detection method thereof
12/29/2010CN101926900A Pediluvium composition and preparing method thereof
12/29/2010CN101926862A Chinese veterinary medicament for enhancing nonspecific immunity function
12/29/2010CN101926861A Method for preparing Chinese medicinal veterinary medicament for enhancing non-specific immune function
12/29/2010CN101926858A External medicinal composition for treating eczema and dermatitis and preparation method thereof
12/29/2010CN101926842A Medicinal composition prepared from raw materials containing snow lotus and fermented cordyceps fungal powder
12/29/2010CN101926840A Ultrafine powder of echinacea and preparation method and application thereof
12/29/2010CN101926835A Method for extracting gingko total terpene lactones and injection containing same
12/29/2010CN101926828A Method for extracting antibacterial substance, water soluble polysaccharide and chitin from blaps
12/29/2010CN101926827A Medicament for preventing and treating small intestine transplantation chronic rejection and application thereof
12/29/2010CN101926826A Method for extracting active ingredients from sea horse
12/29/2010CN101926803A Application of quinazoline compounds
12/29/2010CN101926802A Application of quinazoline compounds
12/29/2010CN101926783A Drug slow control releaser and preparation method thereof
12/29/2010CN101926772A Polysaccharide nucleic acid fraction of bacillus calmette guerin lipid composition for livestock and freeze-dry preparation thereof
12/29/2010CN101926771A Acylated amylopectin-modified BCG-polysaccharide nucleic acid oral veterinary liposome and freeze-dried preparation thereof
12/29/2010CN101926769A Dexamethasone sodium phosphate lipidosome injection
12/29/2010CN101926762A Rupatadine fumarate eye drops and preparation method thereof
12/29/2010CN101926760A Dexamethasone injecta coated with 2-hydroxypropyl-beta-cyclodextrin
1 ... 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 ... 1172